These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7193367)

  • 21. Radical prostatectomy: processing, staging, and prognosis. Parts I and II.
    Epstein JI
    Int J Surg Pathol; 2010 Jun; 18(3 Suppl):118S-123S. PubMed ID: 20484275
    [No Abstract]   [Full Text] [Related]  

  • 22. [Functional results and oncologic control after anatomic radical prostatectomy].
    Rohner S; Graber P
    Ann Urol (Paris); 1994; 28(4):190-5. PubMed ID: 7979208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The combined percentage of Gleason patterns 4 and 5 is the best predictor of cancer progression after radical prostatectomy.
    Cheng L; Koch MO; Juliar BE; Daggy JK; Foster RS; Bihrle R; Gardner TA
    J Clin Oncol; 2005 May; 23(13):2911-7. PubMed ID: 15860849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implementation of a map in radical prostatectomy specimen allows visual estimation of tumor volume.
    Bettendorf O; Oberpenning F; Köpke T; Heinecke A; Hertle L; Boecker W; Semjonow A
    Eur J Surg Oncol; 2007 Apr; 33(3):352-7. PubMed ID: 17175129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.
    Kupelian P; Katcher J; Levin H; Zippe C; Suh J; Macklis R; Klein E
    Cancer J Sci Am; 1997; 3(2):78-87. PubMed ID: 9099457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preoperative prediction of small volume cancer (less than 0.5 ml) in radical prostatectomy specimens.
    Cheng L; Poulos CK; Pan CX; Jones TD; Daggy JK; Eble JN; Koch MO
    J Urol; 2005 Sep; 174(3):898-902. PubMed ID: 16093983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Secondary cancer and relapse rates following radical prostatectomy for prostate-confined cancer.
    Wesley D; Cox HF
    J Insur Med; 2007; 39(4):242-50. PubMed ID: 18522141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of the primary Gleason pattern on prostate needle biopsy with clinico-pathological factors in Gleason 7 tumors.
    Grober ED; Tsihlias J; Jewett MA; Sweet JM; Evans AJ; Trachtenberg J; Robinette M; Nam RK
    Can J Urol; 2004 Feb; 11(1):2157-62. PubMed ID: 15003158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Carcinoma of prostate (author's transl)].
    Hauri D; Lindenberg K
    Schweiz Rundsch Med Prax; 1981 Jun; 70(24):1073-85. PubMed ID: 7019880
    [No Abstract]   [Full Text] [Related]  

  • 30. [The role of radical prostatectomy in cT3 prostate carcinoma].
    Van Poppel H; Goethuys H; Callewaert P; Vanuytsel L; Van de Voorde W; Baert L
    Praxis (Bern 1994); 2001 Sep; 90(38):1623-31. PubMed ID: 11675915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Despite PSA screening and the control by radical prostatectomy, patients treatment fails and have a PSA recurrence.
    Lotan Y
    Eur Urol; 2007 Aug; 52(2):453-4. PubMed ID: 17674436
    [No Abstract]   [Full Text] [Related]  

  • 32. The surgical learning curve for prostate cancer control after radical prostatectomy.
    Vickers AJ; Bianco FJ; Serio AM; Eastham JA; Schrag D; Klein EA; Reuther AM; Kattan MW; Pontes JE; Scardino PT
    J Natl Cancer Inst; 2007 Aug; 99(15):1171-7. PubMed ID: 17652279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maximum Ki-67 staining in prostate cancer provides independent prognostic information after radical prostatectomy.
    Halvorsen OJ; Haukaas S; Høisaeter PA; Akslen LA
    Anticancer Res; 2001; 21(6A):4071-6. PubMed ID: 11911294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A direct comparison of robotic assisted versus pure laparoscopic radical prostatectomy: a single institution experience.
    Rozet F; Jaffe J; Braud G; Harmon J; Cathelineau X; Barret E; Vallancien G
    J Urol; 2007 Aug; 178(2):478-82. PubMed ID: 17561160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Limited value of perineural invasion in radical prostatectomy specimens as a predictor of biochemical recurrence in Japanese men with clinically localized prostate cancer.
    Miyake H; Sakai I; Harada K; Eto H; Hara I
    Hinyokika Kiyo; 2005 Apr; 51(4):241-6. PubMed ID: 15912782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complete embedding and close step-sectioning of radical prostatectomy specimens both increase detection of extra-prostatic extension, and correlate with increased disease-free survival by stage of prostate cancer patients.
    Desai A; Wu H; Sun L; Sesterhenn IA; Mostofi FK; McLeod D; Amling C; Kusuda L; Lance R; Herring J; Foley J; Baldwin D; Bishoff JT; Soderdahl D; Moul JW
    Prostate Cancer Prostatic Dis; 2002; 5(3):212-8. PubMed ID: 12496984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA content of prostatic cancer measured by flow cytometry in patients undergoing radical prostatectomy.
    Romics I; Bocsi J; Bach D; Beutler W; Frang D; Kopper L
    Anticancer Res; 1995; 15(3):1131-4. PubMed ID: 7645937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Visual estimate of the percentage of carcinoma is an independent predictor of prostate carcinoma recurrence after radical prostatectomy.
    Renshaw A
    Cancer; 2002 Apr; 94(8):2310-1; author reply 2311-2. PubMed ID: 12001134
    [No Abstract]   [Full Text] [Related]  

  • 39. Percent carcinoma in prostatectomy specimen is associated with risk of recurrence after radical prostatectomy in patients with pathologically organ confined prostate cancer.
    Ramos CG; Roehl KA; Antenor JA; Humphrey PA; Catalona WJ
    J Urol; 2004 Jul; 172(1):137-40. PubMed ID: 15201754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ability of the 1992 and 1997 American Joint Committee on Cancer staging systems for prostate cancer to predict progression-free survival after radical prostatectomy for stage T2 disease.
    Han M; Walsh PC; Partin AW; Rodriguez R
    J Urol; 2000 Jul; 164(1):89-92. PubMed ID: 10840430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.